β-catenin expression as a strong predictor of recurrence in juvenile angiofibroma
- 20 May 2025
- journal article
- Published by Taylor & Francis in Acta Oto-Laryngologica
- p. 1-6
Abstract
Juvenile angiofibroma (JA) is a rare fibrovascular tumor affecting young males. Although histologically benign, JA is clinically aggressive, with high morbidity, mortality, and recurrence rates. While β-catenin expression is known to contribute to JA growth, its role in recurrence remains uncertain. This study investigates the relationship between β-catenin expression and recurrence risk in JA patients. An analytical observational case-control study was conducted at Dr. Cipto Mangunkusumo Hospital, analyzing 33 JA patients who underwent tumor excision (2013-2022). Patients without recurrence were controls, while those with recurrence were cases. Immunohistochemistry and H-scoring quantified β-catenin expression, and statistical analysis examined its association with recurrence. ROC curves determined cut-off values. Among 33 patients (all male, aged 9-28 years; mean: 16.2 years), 15 had recurrences. High β-catenin expression was significantly associated with recurrence (p = 0.000), with an H-score cut-off of 124.2 (100% sensitivity/specificity). Age ≤18 years correlated with higher recurrence risk (p < .05; OR 8.9). Tumor size, volume, stage, pre-extirpation procedures, surgical techniques, and intraoperative blood loss had no significant effect. High β-catenin expression is a strong predictor of JA recurrence, suggesting its potential as a prognostic marker. Targeting β-catenin pathways may aid in recurrence prevention and improved JA management.Keywords
Funding Information
- Universitas Indonesia (UI) Research Center Cluster (NKB-052/UN2.RST/HKP.05.00/2022)
This publication has 20 references indexed in Scilit:
- Molecular interactions in juvenile nasopharyngeal angiofibroma: preliminary signature and relevant reviewEuropean Archives of Oto-Rhino-Laryngology, 2018
- Nasopharyngeal Angiofibroma: A Clinical, Histopathological and Immunohistochemical Study of 42 Cases with Emphasis on Stromal FeaturesHead and Neck Pathology, 2017
- Recurrence of Juvenile Angiofibroma and its Prevention2017
- Human Papilloma virus in Juvenile Nasopharyngeal Angiofibroma: possible recent trendAmerican Journal of Otolaryngology, 2016
- Nasopharyngeal Angiofibroma-changing Trends in the ManagementIndian Journal of Otolaryngology and Head & Neck Surgery, 2011
- Tumor microenvironmental genomic alterations in juvenile nasopharyngeal angiofibromaHead & Neck, 2011
- Juvenile nasopharyngeal angiofibromas in Denmark 1981–2003: diagnosis, incidence, and treatmentActa Oto-Laryngologica, 2007
- Angiofibroma: an outcome review of conventional surgical approachesEuropean Archives of Oto-Rhino-Laryngology, 2005
- Frequent β-Catenin Mutations in Juvenile Nasopharyngeal AngiofibromasThe American Journal of Pathology, 2001
- Non-epithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx: A clinicopathologic study.I General Features and Vascular TumorsCancer, 1974